These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21989661)

  • 1. High lymph node yield is related to microsatellite instability in colon cancer.
    Belt EJ; te Velde EA; Krijgsman O; Brosens RP; Tijssen M; van Essen HF; Stockmann HB; Bril H; Carvalho B; Ylstra B; Bonjer HJ; Meijer GA
    Ann Surg Oncol; 2012 Apr; 19(4):1222-30. PubMed ID: 21989661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer.
    Cai Z; Song H; Fingerhut A; Sun J; Ma J; Zhang L; Li S; Yu C; Zheng M; Zang L
    BMC Cancer; 2021 Mar; 21(1):319. PubMed ID: 33765970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers.
    Berg M; Guriby M; Nordgård O; Nedrebø BS; Ahlquist TC; Smaaland R; Oltedal S; Søreide JA; Kørner H; Lothe RA; Søreide K
    Mol Med; 2013 Sep; 19(1):286-93. PubMed ID: 23979710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location.
    Søreide K; Nedrebø BS; Søreide JA; Slewa A; Kørner H
    World J Surg; 2009 Dec; 33(12):2695-703. PubMed ID: 19823901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The re-evaluation of optimal lymph node yield in stage II right-sided colon cancer: is a minimum of 12 lymph nodes adequate?
    Cai Y; Cheng G; Lu X; Ju H; Zhu X
    Int J Colorectal Dis; 2020 Apr; 35(4):623-631. PubMed ID: 31996986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma.
    Choi J; Nam SK; Park DJ; Kim HW; Kim HH; Kim WH; Lee HS
    APMIS; 2015 Mar; 123(3):215-22. PubMed ID: 25556520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies.
    Taieb J; Shi Q; Pederson L; Alberts S; Wolmark N; Van Cutsem E; de Gramont A; Kerr R; Grothey A; Lonardi S; Yoshino T; Yothers G; Sinicrope FA; Zaanan A; André T
    Ann Oncol; 2019 Sep; 30(9):1466-1471. PubMed ID: 31268130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
    Mohan HM; Ryan E; Balasubramanian I; Kennelly R; Geraghty R; Sclafani F; Fennelly D; McDermott R; Ryan EJ; O'Donoghue D; Hyland JM; Martin ST; O'Connell PR; Gibbons D; Winter D; Sheahan K
    Eur J Surg Oncol; 2016 Nov; 42(11):1680-1686. PubMed ID: 27370895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon cancer microsatellite instability influences computed tomography assessment of regional lymph node morphology and diagnostic performance.
    Kim YT; Min JH; Choi KH; Kim H
    Eur J Radiol; 2022 Sep; 154():110396. PubMed ID: 35709643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability status does not predict total lymph node or negative lymph node retrieval in stage III colon cancer.
    MacQuarrie E; Arnason T; Gruchy J; Yan S; Drucker A; Huang WY
    Hum Pathol; 2012 Aug; 43(8):1258-64. PubMed ID: 22305240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
    Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
    Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer.
    de Weger VA; Turksma AW; Voorham QJ; Euler Z; Bril H; van den Eertwegh AJ; Bloemena E; Pinedo HM; Vermorken JB; van Tinteren H; Meijer GA; Hooijberg E
    Clin Cancer Res; 2012 Feb; 18(3):882-9. PubMed ID: 22156611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of molecular profile on the lymphatic spread pattern in stage III colon cancer.
    Song J; Kataoka K; Yamada T; Shiozawa M; Sonoyama T; Beppu N; Ueda K; Kuriyama S; Kanazawa A; Ikeda M; Ceelen W
    Cancer Sci; 2021 Apr; 112(4):1545-1555. PubMed ID: 33484192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
    Koenig JL; Toesca DAS; Harris JP; Tsai CJ; Haraldsdottir S; Lin AY; Pollom EL; Chang DT
    Am J Clin Oncol; 2019 Jul; 42(7):573-580. PubMed ID: 31166206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer.
    Oh SY; Kim DY; Kim YB; Suh KW
    World J Surg; 2013 Oct; 37(10):2497-503. PubMed ID: 23754140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph Node Metastases and Associated Recurrence-Free Survival in Microsatellite Stable and Unstable Colon Cancer.
    Hakki L; Khan A; Gonen M; Stadler Z; Segal NH; Shia J; Widmar M; Wei IH; Smith JJ; Pappou EP; Nash GM; Paty PB; Garcia-Aguilar J; Weiser MR
    Ann Surg Oncol; 2023 Dec; 30(13):8487-8494. PubMed ID: 37700171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of Microsatellite Instability Pathway in Outcome of Colon Cancer in Moroccan Population.
    El Agy F; Otmani IE; Mazti A; Lahmidani N; Oussaden A; El Abkari M; Benjelloun EB; Moukit W; El Bouhaddouti H; Toughrai I; Hassani KM; Maazaz K; Benbrahim Z; Mellas N; El Rhazi K; Ouldim K; El Bardai S; Adil Ibrahimi S; Ait Taleb K; Bennis S; Laila C
    Dis Markers; 2019; 2019():3210710. PubMed ID: 31885734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial.
    Klingbiel D; Saridaki Z; Roth AD; Bosman FT; Delorenzi M; Tejpar S
    Ann Oncol; 2015 Jan; 26(1):126-132. PubMed ID: 25361982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.